-
Pine Labs
205.00 283.70(%) -
HDFC Bank
738.70 682.00(%) -
Meesho
244.80 254.65(%) -
Glass Wall Syst.
318.00 318.00(%) -
Cholaman.Inv.&Fn
1,756.50 1,299.80(%) -
Solar Industries
20,243.65 22,630.05(%) -
Cupid
265.35 298.95(%) -
Aster DM Quality
746.55 519.80(%) -
Protean eGov
656.45 940.00(%) -
Gabriel India
1,495.35 1,600.00(%) -
Nippon ETF Liq.
999.99 978.01(%) -
Transrail Light
487.90 800.35(%) -
Reliance Industries
1,237.80 1,232.35(%) -
JSW Dulux
3,131.20 2,649.05(%) -
Kaynes Tech
3,427.35 2,995.85(%) -
Apar Inds.
17,916.55 6,800.00(%) -
Titan Company
4,983.70 5,187.45(%) -
Dixon Technolog.
12,997.00 9,605.05(%) -
Eternal
341.80 368.40(%) -
Larsen & Toubro
3,867.50 3,288.65(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Welcure Drugs & Pharmaceuticals Ltd Trading
- Indian Private
- BSE Code : 4125.0
- ISIN : INE331C01025
-
Today’s Low
0.22 -
Today’s High
0.24
-
Open
0.23 -
Perv Close
0.23 -
52W Low
0.19 -
52W High
0.81
Key Indicators
-
P/E(TTM)
0.00
-
Mar.Cap (₹Cr.)
28.43
-
Div & Yield %
0.00
-
Book Value(₹)
0.79
-
Debt-Equity Ratio
0.00
-
AGM Date
22-Sep-2026
-
EPS
0.00
-
P/E Ratio
0.00
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
28.43
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
123.59
-
BV (₹)
0.80
-
Sales( ₹ in Cr.)
365.54
-
NP (in Cr.)
-5.49
-
NP Var(%)
-353.0
-
Div%
0.0
-
CPS (₹)
0.00
-
EPS (₹)
0.00
-
Traded Value (₹ in Lakhs)
28.43
-
52 Week High
0.81
-
52 Week Low
0.19
-
Price BSE
0.0
-
Price NSE
0.00
-
Market Capital( in Cr.)
28.43
-
P/C Ratio
0.00
-
P/E Ratio
0.00
-
Price Vs.BV
0.00
-
30-May-2026( 03:45)
Results - Announcements - Welcu... - Net loss of Welcure Drugs & Ph...
-
23-May-2026( 05:06)
Corporate News - Welcu... - Welcure Drugs & Pharmaceutical...
-
07-Feb-2026( 04:51)
Corporate News - Welcu... - Welcure Drugs & Pharmaceutical...
-
02-Dec-2025( 12:06)
Corporate News - Welcu... - Welcure Drugs & Pharmaceutical...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 24.55 | 0.00 | 0.00 | 0.11 | 0.13 | 0.08 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 24.55 | 0.00 | 0.00 | 0.11 | 0.13 | 0.08 |
| Other Income | 1.91 | 0.09 | 0.24 | 0.00 | 0.00 | 0.00 |
| Stock Adjustments | 143.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income | 169.98 | 0.09 | 0.24 | 0.11 | 0.13 | 0.08 |
| EXPENDITURE : | ||||||
| Raw Materials | 164.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Power and Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Employee Cost | 0.09 | 0.08 | 0.03 | 0.00 | 0.00 | 0.00 |
| Other Manufacturing Expenses | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling and Administration Expenses | 2.78 | 0.13 | 0.10 | 0.08 | 0.08 | 0.09 |
| Miscellaneous Expenses | 0.17 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Employee Benefit Expenses | 0.09 | 0.08 | 0.03 | 0.00 | 0.00 | 0.00 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 167.11 | 0.23 | 0.13 | 0.08 | 0.08 | 0.09 |
| Operating Profit | 2.88 | -0.14 | 0.10 | 0.02 | 0.06 | -0.01 |
| Interest | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 2.79 | -0.14 | 0.10 | 0.02 | 0.06 | -0.01 |
| Depreciation | 0.01 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit Before Tax | 2.78 | -0.18 | 0.10 | 0.02 | 0.06 | -0.01 |
| Current Tax | 0.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Net Profit | 2.17 | -0.17 | 0.10 | 0.02 | 0.06 | -0.01 |
| Extraordinary Items | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 |
| Adjusted Net Profit | 2.17 | -0.17 | 0.08 | 0.02 | 0.06 | -0.01 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance brought forward | -12.25 | -12.07 | -12.18 | -12.20 | -12.25 | -12.25 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | -10.08 | -12.25 | -12.07 | -12.18 | -12.20 | -12.25 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 0.19 | -0.13 | 0.08 | 0.02 | 0.05 | -0.01 |
| Earnings Per Share(Adj)-Unit Curr | 0.02 | -0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Book Value | 9.12 | 1.00 | 1.13 | 0.08 | 0.06 | 0.01 |
| Book Value(Adj)-Unit Curr | 0.83 | 0.09 | 0.10 | 0.01 | 0.01 | 0.00 |
